<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR23">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Engelman</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Zejnullahu</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Mitsudomi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Song</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Hyland</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>JO</given-names>
   </name>
   <name>
    <surname>Lindeman</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Gale</surname>
    <given-names>CM</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Christensen</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>
   <italic>MET</italic> amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
  </article-title>
  <source>Science</source>
  <year>2007</year>
  <volume>316</volume>
  <fpage>1039</fpage>
  <lpage>43</lpage>
  <pub-id pub-id-type="doi">10.1126/science.1141478</pub-id>
  <?supplied-pmid 17463250?>
  <pub-id pub-id-type="pmid">17463250</pub-id>
 </element-citation>
</ref>
